This approach demonstrated a high rate of cellular uptake and a significant reduction of more than 80% in TyRP-1 protein levels, which is involved in the autoimmune destruction of melanocytes, thus showing great promise for topical therapy of vitiligo [153]. The gene discussed is TYRP1; the disease is vitiligo.